SCHEMBL13660754

SCHEMBL13660754

CC([C@H](C(=O)Nc1cccc(CCC(=O)OC(C)(C)C)c1)c1ccc(CN2Cc3c(F)cccc3C2=O)cc1)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 3/20 0.32
IDH1 O75874 2/20 0.32
PARP1 P09874 1/20 0.32
THRB P10828 1/20 0.32
KCNH2 Q12809 2/20 0.31
TMEM97 Q5BJF2 2/20 0.31
SIGMAR1 Q99720 2/20 0.31
GRM1 Q13255 1/20 0.31
DRD2 P14416 1/20 0.31
ADRA1A P35348 1/20 0.31
DHODH Q02127 1/20 0.31
MAPT P10636 1/20 0.31
DHPS P49366 1/20 0.31
F10 P00742 1/20 0.30
PKM P14618 1/20 0.30
SCN9A Q15858 1/20 0.30
NPY1R P25929 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12872090 1.00 ACKR3 (0.32) ACKR3IDH1PARP1THRBKCNH2
SCHEMBL12872089 1.00 ACKR3 (0.32) ACKR3IDH1PARP1THRBKCNH2
SCHEMBL1178007 1.00 ACKR3 (0.32) ACKR3IDH1PARP1THRBKCNH2
SCHEMBL3690993 0.91 PTGES (0.36) ACKR3IDH1PARP1THRBGRM1
SCHEMBL3705356 0.91 PTGES (0.36) ACKR3IDH1PARP1THRBGRM1
SCHEMBL1177941 0.91 PTGES (0.36) ACKR3IDH1PARP1THRBGRM1
SCHEMBL7602084 0.89 IDH1 (0.34) ACKR3IDH1PARP1THRBGRM1
SCHEMBL1178564 0.88 THRB (0.32) ACKR3IDH1PARP1THRBGRM1
SCHEMBL1178285 0.88 THRB (0.32) ACKR3IDH1PARP1THRBGRM1
SCHEMBL12872088 0.88 THRB (0.32) ACKR3IDH1PARP1THRBGRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009127338-A1 OXO-HETEROCYCLIC SUBSTITUTED CARBOXYLIC ACID DERIVATES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-10-22 WO disclosed